---
title: Northern RNA vs TriLink BioTechnologies
slug_a: northernrna
slug_b: trilinkbiotech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/northernrna/trilinkbiotech
---

# Northern RNA vs TriLink BioTechnologies

Side-by-side profile data from each company listing on this directory.

## Northern RNA

- Profile: [/companies/northernrna](/companies/northernrna)

Northern RNA — Northern RNA is a Calgary, Alberta-based manufacturer of nucleic acids, offering plasmid DNA and mRNA production, chemical manufacturing, and lipid and LNP formulation services. The company also provides analytical and stability testing and development services.

Services: 11. Modalities: 2. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Analytical Method Development & Validation
- API Synthesis & Manufacturing
- Upstream Processing
- Downstream Processing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Process Development
- Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Cold-Chain Storage & Logistics

### Modalities

- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## TriLink BioTechnologies

- Profile: [/companies/trilinkbiotech](/companies/trilinkbiotech)

TriLink BioTechnologies — TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.

Services: 6. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- API Synthesis & Manufacturing
- mRNA Manufacturing
- Oligonucleotide Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Oligonucleotide
- mRNA

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Expression: Cell-Free
- Max chemical: Pilot (10 kg – 100 kg)